Zoledronate in the Prevention of Paget's (zipp): Protocol for a Randomised Trial of Genetic Testing and Targeted Zoledronic Acid Therapy to Prevent SQSTM1-mediated Paget's Disease of Bone
BMJ OPEN(2019)
Key words
Paget's Disease of Bone,bisphosphonate,Zoledronic acid,SQSTM1,genetics,randomized controlled trial
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined